Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-08T07:12:19.775Z Has data issue: false hasContentIssue false

Vagus rules still apply

A commentary on ‘Vagus nerve stimulation for depression: efficacy and safety in a European study’ by Schlaepfer et al. (2008)

Published online by Cambridge University Press:  21 January 2008

D. M. McLoughlin*
Affiliation:
Department of Psychiatry & Trinity College Institute of Neuroscience, Trinity College Dublin, St Patrick's Hospital, Dublin 8, Ireland
*
*Address for correspondence: Professor D. M. McLoughlin, Department of Psychiatry & Trinity College Institute of Neuroscience, Trinity College Dublin, St Patrick's Hospital, Dublin 8, Ireland. (Email: d.mcloughlin@tcd.ie)

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Medicare & Medicaid Services (2007). Decision memo for vagus nerve stimulation for treatment of resistant depression (TRD) (CAG-00313R). (http://www.cms.hhs.gov/MCD/viewdecisionmemo.asp?id=195) Accessed 13 November 2007.Google Scholar
Eranti, S, Mogg, A, Pluck, G, Landau, S, Purvis, R, Brown, RG, Howard, R, Knapp, M, Philpot, M, Rabe-Hesketh, S, Romeo, R, Rothwell, J, Edwards, D, McLoughlin, DM (2007). A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry 164, 7381.Google Scholar
FDA Neurological Devices Panel (2007). Executive Summary of premarket notification (510(k)) submission, K061053, submitted by Neuronetics, Inc., to request marketing clearance for the NeuroStar™ TMS System for the proposed indications for the treatment of Major Depresssive Disorder (http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4273b1_01-FDAExecutiveSummary.pdf). Accessed 13 November 2007.Google Scholar
Herwig, U, Fallgatter, AJ, Hoppner, J, Eschweiler, GW, Kron, M, Hajak, G, Padberg, F, Naderi-Heiden, A, Abler, B, Eichhammer, P, Grossheinrich, N, Hay, B, Kammer, T, Langguth, B, Laske, C, Plewnia, C, Richter, MM, Schulz, M, Unterecker, C, Zinke, A, Spitzer, M, Schonfeldt-Lecuona, C (2007). Antidepressant effects of augmentative transcanial magnetic stimulation. British Journal of Psychiatry 191, 441448.Google Scholar
Lurie, P, Stine, N (2006). Responding to three articles regarding vagus nerve stimulation (VNS) for depression. Biological Psychiatry 60, 13821383.CrossRefGoogle ScholarPubMed
Marangell, LB, Martinez, M, Jurdi, RA, Zboyan, H (2007). Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatrica Scandinavica 116, 174181.Google Scholar
Mogg, A, Pluck, G, Eranti, SV, Landau, S, Purvis, R, Brown, RG, Curtis, V, Howard, R, Philpot, M, McLoughlin, DM (2007). A randomized, controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychological Medicine. Published online: 15 October 2007. doi: 10.1017/S0033291707001663.Google ScholarPubMed
Nahas, Z, Marangell, LB, Husain, MM, Rush, AJ, Sackeim, HA, Lisanby, SH, Martinez, JM, George, MS (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry 66, 10971104.CrossRefGoogle ScholarPubMed
O'Reardon, JP, Solvason, BH, Janicak, PG, Sampson, S, Isenberg, KE, Nahas, Z, McDonald, WM, Avery, D, Fitzgerald, PB, Loo, C, Demitrack, MA, George, MS, Sackeim, HA (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression:a multisite randomized controlled trial. Biological Psychiatry 62, 12081216.CrossRefGoogle ScholarPubMed
Ressler, KJ, Mayberg, HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the lab to the clinic. Nature Neuroscience 10, 11161124.CrossRefGoogle Scholar
Rush, AJ, George, MS, Sackeim, HA, Marangell, LB, Husain, MM, Giller, C, Nahas, Z, Haines, S, Simpson, RK, Goodman, R (2000). Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biological Psychiatry 47, 276286.Google Scholar
Rush, AJ, Marangell, LB, Sackeim, HA, George, MS, Brannan, SK, Davis, SM, Howland, R, Kling, MA, Rittberg, BR, Burke, WJ, Rapaport, MH, Zajecka, J, Nierenberg, AA, Husain, MM, Ginsberg, D, Cooke, RG (2005 a). Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biological Psychiatry 58, 347354.CrossRefGoogle ScholarPubMed
Rush, AJ, Sackeim, HA, Marangell, LB, George, MS, Brannan, SK, Davis, SM, Lavori, P, Howland, R, Kling, MA, Rittberg, B, Carpenter, L, Ninan, P, Moreno, F, Schwartz, T, Conway, C, Burke, M, Barry, JJ (2005 b). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biological Psychiatry 58, 355363.Google Scholar
Sackeim, HA, Brannan, SK, Rush, AJ, George, MS, Marangell, LB, Allen, J (2007). Durability of antidepressant response to vagus nerve stimulation (VNS™). International Journal of Neuropsychopharmacology 10, 817826.CrossRefGoogle ScholarPubMed
Schlaepfer, TE, Frick, C, Zobel, A, Maier, W, Heuser, I, Bajbouj, M, O'Keane, V, Corcoran, C, Adolfsson, R, Trimble, M, Rau, H, Hoff, H-J, Padberg, F, Müller-Siecheneder, F, Audenaert, K, Van den Abbeele, D, Matthews, K, Christmas, D, Stanga, Z, Hasdemir, M (2008). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine. Published online: 4 January 2008. doi: 10.1017/S0033291707001924.Google Scholar
Shuchman, M (2007). Approving the vagus-nerve stimulator for depression. New England Journal of Medicine 356, 16041607.CrossRefGoogle ScholarPubMed